ROC AUC | Sens | Spec | PPV | NPV | LR + | LR − | |
---|---|---|---|---|---|---|---|
Any reduced LV function (mild or severe) (Valid* n= 176) | 0.74 (0.67–0.8) | 74.7% (64–84) | 73.2% (63–82) | 69.4% (59–79) | 78% (68–86) | 2.79 (1.96–3.97) | 0.35 (0.23–0.51) |
Severely reduced LV function (Valid* n= 176) | 0.69 (0.64–0.75) | 43% (32–55) | 95.9% (90–99) | 89.5% (75–97) | 67.4% (59–75) | 10.4 (3.87–28.16) | 0.59 (0.49–0.72) |
B lines any side (Valid* n= 190) | 0.72 (0.65–0.78) | 76.8% (66–85) | 66.7% (57–75) | 63.6% (53–73) | 79.1% (69–87) | 2.30 (1.72–3.09) | 0.35 (0.23–0.53) |
Bilateral B-lines (Valid* n= 186) | 0.73 (0.67–0.8) | 70.9% (60–81) | 75.7% (67–84) | 68.3% (57–78) | 77.9% (69–85) | 2.92 (2.03–4.19) | 0.38 (0.27–0.55) |
Pleural effusion any side (Valid* n= 177) | 0.64 (0.57–0.71) | 42.7% (31–55) | 85.3% (77–92) | 68.1% (53–81) | 66.9% (58–75) | 2.9 (1.70–4.96) | 0.67 (0.54–0.83) |
Bilateral pleural effusion (Valid* n= 178) | 0.59 (0.53–0.65) | 25.7% (16–37) | 92.3% (85–97) | 70.4% (40–86) | 63.6% (55–71) | 3.34 (1.54–7.21) | 0.81 (0.7–0.93) |
Severely reduced LV function and bilateral b-lines (Valid* n= 190) | 0.65 (0.59–0.7) | 31.2% (21–43) | 98.2% (94–100) | 92.3% (75–99) | 67.7% (60–75) | 17.61 (4.29–72.36) | 0.7 (0.6–0.82) |
Severely reduced LV function and bilateral pleural effusion (Valid* n= 191) | 0.55 (0.52–0.59) | 11.5% (5–21) | 99.1% (95–100) | 90% (56–100) | 61.9% (54–69) | 13.04 (1.69–100.85) | 0.89 (0.82–0.97) |
Bilateral B-lines and bilateral pleural effusion (Valid* n= 181) | 0.57 (0.52–0.62) | 16.7% (9–27) | 97.2% (92–99) | 80% (52–96) | 63.6% (56–71) | 6.06 (1.77–20.71) | 0.86 (0.77–0.95) |
Any of severely reduced LV function or bilateral b-lines or bilateral pleural effusion (Valid* n= 169) | 0.75 (0.69–0.81) | 87.8% (79–94) | 62.1% (51–72) | 68.6% (58.8–77.3) | 84.4% (73–92) | 2.31 (1.75–3.06) | 0.2 (0.11–0.36) |
Severely reduced LV function and bilateral b-lines and bilateral pleural effusion (Valid* n= 191) | 0.55 (0.51–0.58) | 10.4% (4–19) | 99.1% (95–100) | 88.9% (52–100) | 62.1% (55–69) | 11.84 (1.51–92.8) | 0.9 (0.84–0.98) |